Dr. Adrian S. Dobs, MD

Dr. Dobs practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Dobs' NPI, 1639126667, was assigned on May 27, 2006. Dr. Dobs graduated from Albany Medical College of Union University in 1978. Dr. Dobs holds Maryland license D28007.

Dr. Dobs' primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Dobs' primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Dobs is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Dobs to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dobs practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Dobs' primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Dobs is licensed in Maryland.

CMS data shows 72 Medicare services from Dr. Dobs across 1 procedure code in 2024, all of them office visits, for 77 Medicare patients. Medicare paid $8,369 for them.

CMS counts 77 Medicare patients who saw Dr. Dobs in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dobs' median patient age at 61, with 35% women.

In 2024, Dr. Dobs wrote 273 Medicare Part D claims for 55 patients. 56% of them were for generic drugs. CMS names the drug for 187 of them, across 8 drugs with 11 or more claims each, at $138,942 in total drug cost. In 2023, CMS named 164 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Dobs for performance year 2024, reported as part of a group. CMS lists Dr. Dobs as offering telehealth.

Dmand AI links 110 papers to Dr. Dobs, published from 2011 to 2025. 2016 was the busiest year, with 11. The most frequent topics are Testosterone, Hypogonadism and Sex Hormone-Binding Globulin. Dr. Dobs has published most often in J Clin Endocrinol Metab. Dr. Dobs' most frequent co-authors are Frank Palella, MD, Alvin M. Matsumoto, MD and Eric Smith Orwoll, MD.

Dmand AI links Dr. Dobs to 3 clinical trials. Conditions studied include Congenital Hyperinsulinism, Hip Fractures and Risk Reduction Behavior.

CMS Open Payments shows 252 general payments to Dr. Dobs from 21 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 39% of the total. Antares Pharma, Inc. paid the most, $82,586. It also lists 6 research payments totaling $557 from 2016 to 2017.

Dr. Dobs graduated from Albany Medical College of Union University in 1978.